Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Price Hits Forecast Target with 25.17% Profit

September 01, 2023
QuantWave, the automated forecasting platform, recently achieved success with its price target forecast for ELI LILLY AND COMPANY stock. The forecast signal was initiated on June 9, 2023, at a price of 438.76 $. The predicted direction was long, and on September 1, 2023, the stock price reached the target of 549.19 $, resulting in a profit of 25.17%.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The successful forecast for ELI LILLY AND COMPANY highlights the platform's ability to provide valuable insights for investors looking to maximize profits in the market.

Factors contributing to this stock movement may include strong financial performance, positive industry trends, and favorable market conditions. The significant profit generated from this forecast success demonstrates the potential opportunities available to users of QuantWave when utilizing its forecasting capabilities.

QuantWave offers users access to predictions for a wide range of stocks, presenting potential opportunities for profits in the financial markets. For investors interested in delving deeper into the investment strategy behind QuantWave, exploring the educational resources of QuantSchool is recommended. QuantSchool provides a comprehensive professional investment framework that reveals key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


FCXApril 4, 2025QuantWave Achieves 21.09% Profit Target Forecast for Freeport-McMoran Inc.  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached a price target forecast for Freeport-McMoran Inc., resulting in a profit of 21.09%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....


CVXOctober 27, 2023QuantWave Achieves 5.08% Profit Target Forecast for Chevron Corporation  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit its price target forecast for Chevron Corporation's stock....


TDSOctober 18, 2024TELEPHONE AND DATA SYSTEMS, INC. Hits Price Target Forecast with 32.48% Profit  ~1 min.

On July 16, 2024, QuantWave issued a forecast signal for TELEPHONE AND DATA SYSTEMS, INC. with a predicted direction of long and a price of 21.93 $....


ZTSApril 8, 2025QuantWave Achieves Profit of 12.47% in ZOETIS INC. Stock Forecast  ~1 min.

QuantWave, an automated forecasting platform, successfully reached its price target forecast for ZOETIS INC. with a profit of 12.47%....